The company is demonstrably boosted its progress of an novel therapy for ATTR-CM, leveraging the compound. Preliminary trial information reveals promising improvements for patients diagnosed by a debilitating disease. https://bridgebio207837.ka-blogs.com/95669674/bridgebio-progresses-attr-cm-treatment-through-attruby